"Peru Pharmaceuticals & Healthcare Report Q2 2014" Is Now Available at Fast Market Research
Peru will offer longer-term growth opportunities to foreign pharmaceutical companies. Although per capita medicine spending in the country is among the lowest in Latin America, pharmaceutical companies can generate rapid sales growth due to the lack of mandatory medicine pricing system in Peru. More stringent quality controls, relatively weak domestic pharmaceutical industry, ongoing liberalisation of bilateral trade agreements and the recognition of 'High Sanitary Surveillance' as well as Peru's investor-friendly business environment will further benefit foreign companies.
View full press release